Great Valley Advisor Group Inc. Boosts Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Great Valley Advisor Group Inc. increased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 306.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,850 shares of the biotechnology company’s stock after purchasing an additional 2,902 shares during the period. Great Valley Advisor Group Inc.’s holdings in Axon Enterprise were worth $1,539,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Quent Capital LLC increased its holdings in shares of Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after buying an additional 75 shares during the last quarter. Blue Trust Inc. increased its stake in Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after acquiring an additional 79 shares during the last quarter. Planning Capital Management Corp raised its position in Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock valued at $48,000 after purchasing an additional 55 shares during the period. Friedenthal Financial purchased a new position in shares of Axon Enterprise during the 3rd quarter worth $51,000. Finally, Reston Wealth Management LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter worth about $60,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on AXON. JMP Securities increased their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. Craig Hallum increased their price objective on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Northland Securities upped their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Robert W. Baird lifted their price objective on Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Finally, Needham & Company LLC raised their target price on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Two equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $427.83.

Insiders Place Their Bets

In other Axon Enterprise news, Director Julie A. Cullivan sold 900 shares of the firm’s stock in a transaction on Thursday, September 5th. The stock was sold at an average price of $353.53, for a total value of $318,177.00. Following the sale, the director now directly owns 3,653 shares in the company, valued at $1,291,445.09. This trade represents a 19.77 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the transaction, the president now directly owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. This represents a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 260,256 shares of company stock worth $105,984,120 in the last 90 days. Corporate insiders own 5.70% of the company’s stock.

Axon Enterprise Stock Down 2.8 %

AXON stock opened at $619.00 on Tuesday. The company’s 50 day moving average price is $468.24 and its 200 day moving average price is $370.65. The firm has a market capitalization of $47.20 billion, a price-to-earnings ratio of 159.95, a PEG ratio of 14.02 and a beta of 0.94. Axon Enterprise, Inc. has a fifty-two week low of $224.28 and a fifty-two week high of $641.20. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.